Quality of life in a randomized control trial? Comments concerning MA 17.
This
Pascale
P
de la Rochefordière
Anne
A
Bredart
Anne
A
Asselain
Bernard
B
Poinsot
Rollon
R
Dolbeault
Sylvie
S
Sigal-Zafrani
Brigitte
B
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D015982:Bias; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D015986:Confounding Factors, Epidemiologic; D003627:Data Interpretation, Statistical; D005260:Female; D006801:Humans; D000077289:Letrozole; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy; D009570:Nitriles / Q000627:therapeutic use*; D010349:Patient Compliance; D010352:Patient Dropouts; D017698:Postmenopause; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D011795:Surveys and Questionnaires; D016019:Survival Analysis; D014230:Triazoles / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014230:Triazoles; D000077289:Letrozole